Article
Reliability of H3K27M Detection Using a Commercially Available Blood-based Comprehensive Genomic Profiling Test in Patients with Diffuse Midline Gliomas: Analysis of the Nationwide C- CAT Database in Japan
2025-11-07
Abstract excerpt
<title>Abstract</title> <p>Purpose This study aimed to assess the ability of FoundationOne Liquid CDx (F1 Liquid), a blood-based comprehensive genomic profiling test introduced in Japan in 2021, to detect the H3K27M mutation in patients with diffuse midline glioma using a nationwide database in Japan. Methods We identified patients with IDH-wildtype diffuse gliomas in midline locations registered in the Center fo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8b2589ad-f3c2-5745-a656-e26369b9a842
- DOI
- 10.21203/rs.3.rs-7932452/v1
